GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (NAS:TVGN) » Definitions » FCF Margin %

TVGN (Tevogen Bio Holdings) FCF Margin % : 0.00% (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tevogen Bio Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Tevogen Bio Holdings's Free Cash Flow for the three months ended in Sep. 2024 was $-3.81 Mil. Tevogen Bio Holdings's Revenue for the three months ended in Sep. 2024 was $0.00 Mil. Therefore, Tevogen Bio Holdings's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

As of today, Tevogen Bio Holdings's current FCF Yield % is -2.22%.

The historical rank and industry rank for Tevogen Bio Holdings's FCF Margin % or its related term are showing as below:


TVGN's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -131.635
* Ranked among companies with meaningful FCF Margin % only.


Tevogen Bio Holdings FCF Margin % Historical Data

The historical data trend for Tevogen Bio Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tevogen Bio Holdings FCF Margin % Chart

Tevogen Bio Holdings Annual Data
Trend Dec21 Dec22 Dec23
FCF Margin %
- - -

Tevogen Bio Holdings Quarterly Data
Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Tevogen Bio Holdings's FCF Margin %

For the Biotechnology subindustry, Tevogen Bio Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tevogen Bio Holdings's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tevogen Bio Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Tevogen Bio Holdings's FCF Margin % falls into.


;
;

Tevogen Bio Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Tevogen Bio Holdings's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-1.376/0
= %

Tevogen Bio Holdings's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-3.805/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tevogen Bio Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of Tevogen Bio Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tevogen Bio Holdings Business Description

Traded in Other Exchanges
Address
15 Independence Boulevard, Warren, NJ, USA, 07059
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.